HIV, the virus that causes AIDS, began as a simian immunodeficiency virus (SIV) living harmlessly in African primates and jumped into humans on at least a dozen separate occasions over the past century or so. The strain responsible for the global pandemic, HIV-1 group M, traces back to chimpanzees in southeastern Cameroon, with genetic evidence placing its earliest common ancestor in human populations around the 1920s. What turned a handful of localized infections into a worldwide epidemic was not just the initial animal-to-human jump but a cascade of social, medical, and geographic factors in colonial central Africa that gave the virus the foothold it needed.
From Chimpanzees and Mangabeys to Humans
There are two major types of HIV. HIV-1, which accounts for the vast majority of infections worldwide, originated in chimpanzees and, in some lineages, gorillas in west central Africa. HIV-2, a less transmissible and less virulent type found mainly in West Africa, came from sooty mangabeys, a species of Old World monkey. These were not single, one-time events. Genetic analyses show that HIV-1 entered humans through at least four independent cross-species transmissions, producing four recognized groups labeled M, N, O, and P. HIV-2 crossed over at least eight separate times, producing its own distinct groups, though only two of those (groups A and B) spread widely enough to become epidemic.
The chimpanzee subspecies responsible for HIV-1 is Pan troglodytes troglodytes, whose natural range in west central Africa overlaps precisely with the regions where HIV-1 groups M, N, and O are endemic.1PubMed. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes Researchers traced the pandemic strain (group M) and the rare group N to distinct, geographically separated chimpanzee communities in Cameroon.2PubMed Central. Chimpanzee reservoirs of pandemic and nonpandemic HIV-1 Group O, which has infected roughly 100,000 people in west central Africa, appears to have reached humans through gorillas rather than directly from chimpanzees. Researchers sequenced gorilla SIV strains in Cameroon that were very closely related to group O, pointing to western lowland gorillas as the immediate source of that lineage.3PubMed Central. Origin of the HIV-1 group O epidemic in western lowland gorillas The chimpanzees themselves likely acquired their version of SIV long before any of these human transmissions, through a recombination event involving viruses from other monkey species they prey on.4Cell Host & Microbe. Gene Loss and Adaptation to Hominids Underlie the Ancient Origin of HIV-1
HIV-2’s origin story is parallel but separate. Sooty mangabeys in West Africa carry SIVsmm, and genetic clustering of wild mangabey viruses with the epidemic groups of HIV-2 points to the eastern part of the mangabey’s range, in what is now Côte d’Ivoire, as a likely geographic source.5PubMed Central. Simian immunodeficiency virus infection in free-ranging sooty mangabeys (Cercocebus atys atys) from the Taï Forest, Côte d’Ivoire And these crossovers are not confined to the distant past. Researchers working in rural Côte d’Ivoire identified a novel HIV-2 variant unrelated to any previously defined group, demonstrating that sooty mangabey viruses continue to jump into humans, causing new zoonotic infections.6PubMed Central. Evidence for continuing cross-species transmission of SIVsmm to humans
How the Virus Crossed the Species Barrier
The standard shorthand for how SIV reached humans is the “cut hunter” hypothesis: a person hunting or butchering an infected chimpanzee was exposed to its blood through a wound, and the virus established itself in the human body. Bushmeat hunting was and remains common in central Africa, and blood-to-blood contact during butchering is a plausible route for a retrovirus to cross species lines. The scenario is almost certainly part of the story, but researchers have argued that it is too simple on its own. A historical epidemiology analysis concluded that the “cut hunter” framing relies on an ecological oversimplification of human-chimpanzee interactions and cannot by itself explain how a single initial infection ignited an epidemic.7PubMed. Beyond the Cut Hunter: A Historical Epidemiology of HIV Beginnings in Central Africa
The problem is that a hunter getting infected once does not automatically produce an epidemic. SIV likely entered individual humans many times over centuries or millennia, producing dead-end infections that went nowhere. What was different about the early twentieth century was not the initial jump but the conditions that allowed the virus to spread from person to person fast enough to adapt and sustain itself. The real question is less “how did the first human get infected” and more “why did the virus finally take off when it did.”
When It Started and Where It Spread
Molecular clock analyses, which estimate the age of a virus lineage by measuring how much its genetic sequences have diverged, consistently date the most recent common ancestor of HIV-1 group M to the first few decades of the twentieth century. One landmark estimate placed it at 1931, with a confidence range of 1915 to 1941.8PubMed. Timing the ancestor of the HIV-1 pandemic strains A later analysis using different methods found a median date of about 1922, with a wider range stretching from 1861 to 1948, consistent with other major studies placing the origin within the first three decades of the 1900s.9PubMed Central. Evidence for a recombinant origin of HIV-1 Group M from genomic variation These dates tell us when the human-adapted virus began diversifying, not necessarily the exact moment of the animal-to-human jump, which could have been somewhat earlier.
The geographic epicenter of that early diversification was Kinshasa, in what is now the Democratic Republic of the Congo. Statistical modeling of HIV-1 sequences from across central Africa showed that Kinshasa was the focus of early transmission from the 1920s onward and the source of pandemic viruses that later appeared elsewhere before 1960.10PubMed Central. HIV epidemiology. The early spread and epidemic ignition of HIV-1 in human populations. The ancestor virus probably arrived in the city from southeastern Cameroon, where chimpanzees carrying the closest SIV relatives live. Regular steamship lines linked the two locations from around 1900, providing a plausible route for an infected person to carry the virus downriver to the rapidly growing colonial capital.11PubMed Central. Newly Discovered Archival Data Show Coincidence of a Peak of Sexually Transmitted Diseases with the Early Epicenter of Pandemic HIV-1
Physical proof that HIV-1 was already circulating and diversifying in Kinshasa by mid-century came from archival medical specimens. Researchers recovered and sequenced viral RNA from a preserved lymph node biopsy taken from a woman in Léopoldville (Kinshasa’s colonial-era name) in 1960. The genetic sequence was already substantially divergent from other early HIV-1 strains, confirming that the virus had been diversifying in the city for decades by that point.12PubMed Central. Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960
Why the Virus Took Off in Colonial Central Africa
The timing of HIV-1’s emergence is not coincidental. The early twentieth century brought enormous social upheaval to central Africa under colonial rule. Léopoldville transformed from a small trading post into one of the largest cities in equatorial Africa, attracting migrant laborers and creating conditions that would be ideal for a sexually transmitted pathogen: large, mobile populations, widespread sex work, and extremely high rates of other sexually transmitted infections that cause genital ulcers, which make HIV transmission far more efficient.
Archival data from the colonial period reveal that STD rates in Léopoldville peaked dramatically during the era when the ancestor virus of group M was establishing itself. High rates of genital ulcers and other STDs among both European colonists and the African population likely gave a critical boost to the sexual spread of a virus that was still poorly adapted to humans, helping it chain from person to person fast enough to gain a permanent foothold.11PubMed Central. Newly Discovered Archival Data Show Coincidence of a Peak of Sexually Transmitted Diseases with the Early Epicenter of Pandemic HIV-1
Medical practices of the era also played a role. The city’s sexually transmitted disease clinic administered up to 500 injections per day using syringes and needles that were merely rinsed between patients, not sterilized.13Sexually Transmitted Infections. The expansion of HIV-1 in colonial Léopoldville, 1950s: driven by STDs or STD control? Mass vaccination campaigns and treatment programs for diseases like sleeping sickness used similar needle-reuse practices. Each reused needle was an opportunity for blood-borne transmission. Ironically, colonial public health infrastructure may have amplified the very epidemic it would have wanted to prevent.
Transport networks mattered too. The Congo River and its tributaries, along with new railway lines, connected remote forest communities where the initial animal-to-human jumps occurred to the booming urban center of Léopoldville. Once the virus was circulating in a city of hundreds of thousands, it had the population density and mobility to sustain itself indefinitely. Research modeling the epidemic’s early dynamics found that group M underwent a clear epidemiological transition around 1960, outpacing regional population growth and beginning its exponential spread.10PubMed Central. HIV epidemiology. The early spread and epidemic ignition of HIV-1 in human populations.
The Route to the Americas and Beyond
HIV-1 subtype B, the strain responsible for the epidemic in the Western Hemisphere, did not arrive directly from central Africa. Genetic analysis of archival samples from some of the earliest known Haitian AIDS patients showed that the virus moved from Africa to Haiti around 1966 and circulated there for several years before spreading elsewhere. A “pandemic clade” encompassing the vast majority of non-Haitian subtype B infections worldwide then emerged after a single migration event out of Haiti around 1969.14PubMed Central. The emergence of HIV/AIDS in the Americas and beyond
Haiti’s connection to central Africa during the 1960s was not random. After the Congo gained independence in 1960, many Haitian professionals, particularly teachers and technical workers, were recruited to fill positions left vacant by departing Belgian colonists. When they returned to Haiti, some likely carried the virus with them. From Haiti, the virus reached the United States and then spread globally. The first recognized AIDS cases were reported in 1981 among gay men in Los Angeles and New York, but the virus had been silently circulating in the U.S. for over a decade before anyone noticed.
The “Patient Zero” Myth
For years, a French-Canadian flight attendant named Gaëtan Dugas was blamed as the person who introduced HIV to the United States, branded “Patient Zero” by journalist Randy Shilts in his 1987 book. The label stuck in the public imagination and did real damage, reinforcing stigma and misunderstanding about how the epidemic began. Genetic analysis of preserved viral samples from Dugas and from other early American patients eventually cleared his name definitively. The virus arrived in New York City from the Caribbean around 1970, and there was nothing in Dugas’s viral sequences that implicated him or his behavior as key to the epidemic’s subsequent rapid spread.15Nature. How researchers cleared the name of HIV Patient Zero Dugas was one of many early cases, not the spark that lit the fire.
The Contaminated Polio Vaccine Theory
Another prominent origin theory, advanced most forcefully by journalist Edward Hooper in his 1999 book “The River,” proposed that HIV entered humans through contaminated oral polio vaccine (OPV) administered in central Africa in the late 1950s. The idea was that the vaccine had been grown in chimpanzee kidney cells infected with SIV, and mass vaccination campaigns had inadvertently introduced the virus to millions of people. It was a dramatic claim that generated serious scientific investigation, but the evidence has consistently gone against it.
First, molecular analyses of original OPV samples from the relevant production lots found no trace of chimpanzee DNA. The vaccine had been prepared using monkey cells, not chimpanzee cells.16PubMed. Molecular analyses of oral polio vaccine samples Second, researchers collected SIV from wild chimpanzees living in the region where the vaccine trials took place and found that the circulating virus was phylogenetically distinct from all known strains of HIV-1, meaning those chimpanzees could not have been the source of the human pandemic.17PubMed. Origin of AIDS: contaminated polio vaccine theory refuted Third, molecular clock dating places the common ancestor of HIV-1 group M decades before the vaccine trials began. The virus was already diversifying in humans by the 1920s or 1930s, long before the first polio vaccine was developed.
What Made Group M the Pandemic Strain
Of the four groups of HIV-1 that crossed into humans, only group M went on to infect tens of millions of people globally. Groups N and P have been found in only a handful of individuals, and group O, while more successful, remains largely confined to Cameroon and neighboring countries. Why the dramatic difference? Part of the answer is surely circumstance: where and when the virus landed and what social conditions surrounded it. But there is growing evidence that group M also had a specific molecular advantage.
When a virus jumps from one species to another, it has to overcome the new host’s antiviral defenses. One key human defense is a protein called tetherin (also known as BST-2), which traps newly made virus particles on the surface of infected cells, preventing them from spreading. Most SIV strains use a protein called Nef to counteract tetherin in their primate hosts, but human tetherin is structured differently, and Nef does not work against it.18Current HIV Research. Adaptation of Human and Simian Immunodeficiency Viruses for Resistance to Tetherin/BST-2 HIV-1 group M solved this problem by evolving a different viral protein, Vpu, to neutralize human tetherin. Crucially, only group M evolved a fully functional Vpu with this capability, out of the three independent cross-species transmissions that produced groups M, N, and O. This molecular adaptation may be a key reason why group M viruses, and essentially only group M viruses, achieved pandemic spread.19PubMed Central. Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains
How Old Is SIV Itself
The question of how long SIV has been circulating in African primates is surprisingly contentious. For years, the assumption was that SIV and its primate hosts had been coevolving for millions of years, driven by the observation that many infected primate species show little or no disease from their native SIV strain, a hallmark of long-standing host-pathogen relationships. But molecular clock estimates have challenged that picture.
One study using relaxed molecular clock methods estimated the most recent common ancestor of SIV in chimpanzees at around 1492 and in sooty mangabeys at around 1809, strikingly young dates that suggest the entire SIV family tree might be only thousands or tens of thousands of years old rather than millions.20PLoS Computational Biology. Dating the Age of the SIV Lineages That Gave Rise to HIV-1 and HIV-2 A competing approach used biogeography rather than molecular clocks, taking advantage of the fact that SIV lineages exist on Bioko Island, which was separated from the African mainland by rising sea levels at the end of the last ice age. Because the island’s monkeys have been isolated from mainland populations for at least 32,000 years, and their SIV strains cluster with mainland viruses of the same host genus rather than with each other, the virus must have been present in those hosts before the island separated. That finding establishes SIV as at least 32,000 years old, considerably older than the molecular clock estimates suggest.21PubMed. Island biogeography reveals the deep history of SIV
The discrepancy remains unresolved and is genuinely interesting. Molecular clocks in RNA viruses are calibrated using known time points that are relatively recent, and extrapolating backward over tens of thousands of years introduces substantial uncertainty. It is possible that SIV’s mutation rate has slowed over deep time as host and virus reached a more stable equilibrium, which would make molecular clock estimates artificially young. Whatever the true age, the broader point stands: SIV had been jumping among African primate species for a very long time before it found its way into humans. What was missing was not the opportunity for cross-species transmission but the right combination of social conditions to let it sustain itself in a new host.
Why New Crossovers Still Happen
The origin of HIV is not a sealed historical chapter. Bushmeat hunting and butchering continue across West and Central Africa, and the same exposure routes that produced HIV-1 and HIV-2 remain active. The discovery of a novel HIV-2 variant in rural Côte d’Ivoire, unrelated to any previously characterized group, is direct evidence that sooty mangabey SIV strains continue to cross into humans.6PubMed Central. Evidence for continuing cross-species transmission of SIVsmm to humans Whether any of these new introductions could spark another epidemic depends on the same factors that determined the fate of past crossovers: how well the virus adapts to human defenses, how much sustained person-to-person transmission occurs before the infection chain dies out, and what conditions exist to amplify early spread. Modern surveillance and antiviral treatment provide defenses that did not exist in the early twentieth century, but the underlying zoonotic risk has not disappeared.